Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar Lines
Clinical trial NCT06151561 · COMPLETED
Trial details
- NCT number
- NCT06151561
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-05
- Primary completion
- 2024-04-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.